GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 52 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $50,000 | -51.0% | 10,500 | -65.6% | 0.01% | -53.3% |
| Q4 2017 | $102,000 | +56.9% | 30,500 | 0.0% | 0.02% | +50.0% |
| Q3 2017 | $65,000 | -13.3% | 30,500 | 0.0% | 0.01% | -23.1% |
| Q2 2017 | $75,000 | +7.1% | 30,500 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $70,000 | +133.3% | 30,500 | 0.0% | 0.01% | +116.7% |
| Q4 2016 | $30,000 | -11.8% | 30,500 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $34,000 | -24.4% | 30,500 | 0.0% | 0.01% | -30.0% |
| Q2 2016 | $45,000 | +2.3% | 30,500 | 0.0% | 0.01% | +11.1% |
| Q1 2016 | $44,000 | -12.0% | 30,500 | 0.0% | 0.01% | -10.0% |
| Q4 2015 | $50,000 | -29.6% | 30,500 | 0.0% | 0.01% | -41.2% |
| Q3 2015 | $71,000 | -14.5% | 30,500 | 0.0% | 0.02% | +6.2% |
| Q2 2015 | $83,000 | -18.6% | 30,500 | 0.0% | 0.02% | -15.8% |
| Q1 2015 | $102,000 | -3.8% | 30,500 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $106,000 | -4.5% | 30,500 | +38.6% | 0.02% | -9.5% |
| Q3 2014 | $111,000 | – | 22,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
| Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
| RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
| OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
| Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
| Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |